| 1. |
1. Humphreys, A. and Boersig, C. (2003) Cholesterol drugs dominate. MedAdNews. 22, 42–57.
|
| |
| 2. |
2. Glennie, M. J. and Johnson, P.W.M. (2000) Clinical Trials of Antibody Therapy. Immunol. Today. 21, 403–410.
|
| |
| 3. |
3. Gottschalk U. (2003) Biotech Manufacturing Is Coming of Age. BioProcess International. 1, 54–61.
|
| |
| 4. |
4. Jefferis, R. (2005) Glycosylation of Recombinant Antibody Therapeutics. Biotechnol. Prog.
21, 11–16.
|
| |
| 5. |
5. Lund J., Takahashi, N., Popplewell, A., Goodall, M., Pound, J. D., Tyler, R., King, D. J., and Jefferis, R. (2000) Expression
and characterization of truncated glycoforms of humanized L243 IgG1: architectural features can influence synthesis of its
oligosaccharide chains and affect superoxide production triggered through human FcγR1. Eur. J. Biochem.
267, 7246–7257.
|
| |
| 6. |
6. Stockert, R. J. (1995) The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev.
75, 591–609.
|
| |
| 7. |
7. Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H-H., Brown, G.D., and Gordon S. (2005) Macrophage receptors and
immune recognition. Ann Rev Immunol. 23, 901–944.
|
| |
| 8. |
8. Raju, T. S., Briggs, J. B., Borge, S. M., and Jones A. J. S. (2000) Species-specific variation in glycosylation of IgG:
evidence for the species-specific sialylation and branch-specific galac-tosylation and importance for engineering recombinant
glycoprotein therapeutics. Glycobiology. 10, 477–486.
|
| |
| 9. |
9. Noguchi, A., Mukuria C. J., Suzuki, E., and Naiki, M. (1995) Immunogenicity of N-glycolyl-neuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in chinese hamster
ovary cells. Biochem. Japanese Biochem. Soc.
117, 59–62.
|
| |
| 10. |
10. Wilson, I. B. H., Zeleny, R., Kolarich, D., Staudacher, E., Stroop, C. J. M., Kamerling, J. P., and Altmann, F. (2001)
Analysis of Asn-linked glycans from vegetable foodstuffs: widespread occurrence of Lewis a, core α1,3-linked fucose and xylose
substitutions. Glycobiology. 11, 261–274.
|
| |
| 11. |
11. Garcia-Casado, G., Sanchez-Monge, R., Chrispeels, M. J., Armentia, A., Salcedo, G., and Gomez, L. (1996) Role of complex
asparagine-linked glycans in the allergenicity of plant glycoproteins. Glycobiology. 6, 471–477.
|
| |
| 12. |
12. Galili, U., Rachmilewitz, E.A., Peleg, A., and Flechner, I. (1984) A unique natural human IgG antibody with anti-α-galactosyl
specificity. J. Exp. Med.
160, 1519–1531.
|
| |
| 13. |
13. Galili U. and Matta, K. L. (1996) Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides.
Transplantation. 62, 356–362.
|
| |
| 14. |
14. Wang, L., Anaraki, F., Henion, T. R., and Galili, U. (1995) Variations in activity of the human natural anti-Gal antibody
in young and elderly populations. J. Gerontol. (Med. Sci.) 50A, M227–M233.
|
| |
| 15. |
15. Harvey, D. J. (2001) Identification of protein-bound carbohydrates by mass spectrometry. Proteomics.
1, 311–328.
|
| |
| 16. |
16. Anumula, K. R. and Dhume, S. T. (1998) High resolution and high sensitivity methods for oligosaccharide mapping and characterization
by normal phase high performance liquid chro-matography following derivatization with highly fluorescent anthranilic acid.
Glycobiology. 8, 685–694.
|
| |
| 17. |
17. Dhume, S. T., Ebert, M. B., Saddic, G. N., and Anumula, K. R. (2002) Monitoring glycosyla-tion of therapeutic glycoproteins
for consistency using highly fluorescent anthranilic acid in Methods in Molecular Biology, Posttranslational Modifications of Proteins. (Kannicht, C., ed), Humana, Totowa, NJ, pp. 127–142.
|
| |
| 18. |
18. Anumula, K. R. (1995) Novel fluorescent methods for quantitative determination of monosac-charides and sialic acids in
glycoproteins by reversed phase high performance liquid chromatography in Methods in Protein Structure Analysis (Atassi, M. Z. and Apella, E., eds.), Plenum, New York, NY, pp. 195–206.
|
| |
| 19. |
19. Anumula, K. R. (1997) Highly sensitive pre-column derivatization procedures for quantitative determination of monosaccharides,
sialic acids and amino sugar alcohols of glycoproteins by reversed phase HPLC in Techniques in Glycobiology (Townsend, R. R. and Hotchkiss, A. T., eds.), Marcel Dekker, New York, NY, pp. 349–357.
|
| |
| 20. |
20. Anumula, K.R. (2006) Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis
of glycoprotein carbohydrates. Anal. Biochem.
350, 1–23.
|
| |
| 21. |
21. Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., and
Butters, T. D. (2004) Analysis of fluorescently labeled glycosphingoli-pid-derived oligosaccharides following ceramide glycanase
digestion and anthranilic acid labeling. Anal. Biochem.
331, 275–282.
|
| |